Chemical, Structural, Clinical and Biological details of Antiviral agents ID: DrugRepV_4748



Chemical Information
Antiviral agent IDDrugRepV_4748
Antiviral agent namesodium (2S)-2-[(2S)-2-{[({1-[(tert-butoxy)carbonyl]piperidin-4-yl}oxy)carbonyl]amino}-4-methylpentanamido]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonate
IUPAC Namesodium (2S)-2-[(2S)-2-{[({1-[(tert-butoxy)carbonyl]piperidin-4-yl}oxy)carbonyl]amino}-4-methylpentanamido]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonate PubChem
SMILES (canonical)[Na+].CC(C)C[C@H](NC(=O)OC1CCN(CC1)C(=O)OC(C)(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(O)S([O-])(=O)=O PubChem
Molecular FormulaC24H41N4NaO10S PubChem
Molecular Weight (g/mol)600.66 PubChem
Structural Information
  
Clinical Information
Biological Information
Secondary Indication Middle East respiratory syndrome coronavirus (MERS-CoV) NA NAWorld Health OrganisationCDC
Secondary Indication (Approaches)Experimental
Secondary Indication (Methods)In-vitro
Secondary Indication (Mode of viral infection)Adsorption
Secondary Indication (Viral titer)0.01 MOI
Secondary Indication (Mode of drug delivery) Culture
Secondary Indication (Drug concentration)0.4 μM
Secondary Indication (Cell based assay)FRET protease assay
Secondary Indication (Change)Decrease
Secondary Indication (Type of Inhibition) IC50 [ 50 % ]
ReferenceGalasiti Kankanamalage AC, Kim Y, Damalanka VC, Rathnayake AD, Fehr AR, Mehzabeen N, Battaile KP, Lovell S, Lushington GH, Perlman S, Chang KO, Groutas WC..Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element..Eur J Med Chem. 2018 Apr 25;150:334-346. doi: 10.1016/j.ejmech.2018.03.004. Epub 2018 Mar 6. PubMed PMID:29544147 PubMed
CommentThe mechanism of action of the compounds and the structural determinants associated with binding were illuminated using X-ray crystallography.